PORTFOLIO COMPANION DIAGNOSTICS ENABLING TECHNOLOGIES RESOURCES OUR CULTURE About Contact Careers Search HomePortfolioArmored RNA Quant® SARS-CoV-2 Controls Armored RNA Quant® SARS-CoV-2 Armored Controls have been utilized in FDA-approved assays for last 20+ years and continue to serve as an important tool in the rapidly evolving space of molecular diagnostics. Our new Armored RNA Quant SARS-CoV-2 SV1 (Spike Variant) control provides safe and reliable detection of the UK (B.1.1.7), South African (B.1.351), Brazilian (P.1), and Delta (B.1.617.2) variant strains of the novel Coronavirus. Armored RNA Quant® controls allow for stable, reliable, and safe ways to rapidly test for the presence of Coronavirus and its variants. Each control encodes in vitro transcribed RNA encapsulated in a protective protein coat to create a virus-like particle resistant to nuclease degradation. This allows the product to be used as RNA extraction controls, process quality controls, or positive diagnostic reference controls. From feasibility to clinical use, these robust and versatile controls are beneficial across all sectors of the research and diagnostic spectrum. Armored RNA Quant® SARS-CoV-2 Controls Concentration: 1 x 106 copies/mL and can be customized Buffer Composition: TSM III (10 mM Tris, 100 nM NaCl, 1 mM MgCl2, 0.1% Gelatin, 0.3% Microcide III, pH 7.0) Storage at -15 to -30°C Features & Benefits Armoring Process Flow Ordering Information Detailed Sequences Features & Benefits Reduced Complexity Available as standalone catalog item High-quality solution to monitor extraction and process efficiency Compatible with a wide range of RNA-based clinical assays Non-infectious, synthetic constructs simplify shipping and storage Optimized Workflow Deployable as extractable, exogenous internal positive control Tailored sequences specific to SARS-CoV-2 and RNase P Degradation resistant in majority of biological matrices Multiple volume and manufacturing options available Available as cGMP or development lot in a range of fill volumes Quality Performance Concentration determined using National Institute of Standards (NIST) traceable standard Highly standardized, quality controlled manufacturing ensures reliability and consistency between lots Manufactured in a cell-free system Armoring Process Flow SARS-CoV-2 Targets the N1, N2 region of the CDC recommended Diagnostic Panel (CDC-006-00019). SARS-CoV-2 Panel SARS-CoV-2 SV1 Ordering Information Detailed Sequences SARS-CoV-2 and RNase P View Detailed Sequences SARS-CoV2 Panel View Detailed Sequences SARS-CoV2 SV1 View Detailed Sequences * For Research Use Only. Not For Use in Diagnostic Procedures. MolecularDx Controls Armored RNA Quant® Respiratory Triplex Control SARS-CoV-2 Controls Brochure SARS-CoV-2 Product Sheet SARS-CoV-2 Panel Product Sheet SARS-CoV-2 SV1 Product Sheet Armored RNA IPC Brochure MolecularDx Catalog Questions? Send Us an Email Place an Order 2150 Woodward St., Suite 100 Austin, TX 78744 USA PORTFOLIO COMPANION DIAGNOSTICS ENABLING TECHNOLOGIES RESOURCES COMMUNITY About Contact Careers © Copyright 2021 ASURAGEN, INC. An Equal Opportunity Employer. All Rights Reserved. Privacy Policy Website Terms of Use Financial Conflict of Interest Policy